Aclarion, Inc.(ACON)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,775 of 2,961 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Unusual Activity in ACON
Events flagged as statistical outliers against ACON's own multi-year baseline — not fixed dollar thresholds.
- Insider cluster2026-08-17
6 insiders bought $125,670 of ACON in 30 days — 7.0σ above this company's 2-year norm
View source filing → - Insider cluster2026-08-14
5 insiders bought $109,681 of ACON in 30 days — 5.7σ above this company's 2-year norm
View source filing →
ACON Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for Aclarion, Inc. (ACON), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ACON at 20.3/100 on a 32-signal composite quality model, placing it at rank #2,775 of 2,961 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Aclarion, Inc. reports quarterly revenue of $25.2K, net income of $-2.7M. Top institutional holders of ACON by reported 13-F value include BRIDGEWAY CAPITAL MANAGEMENT, CAPTRUST FINANCIAL ADVISORS, VANGUARD FIDUCIARY, based on the most recent SEC filings. ACON trades on the Nasdaq exchange and files with the SEC under CIK 1635077. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ACON daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Aclarion, Inc. directly from SEC EDGAR. Aclarion, Inc.'s 13F Pro composite quality score has ranged between 17 and 23 since 2026, currently 20.3 — an improving long-term trajectory across 8 quarterly and live scoring snapshots.
Revenue
Q2 2026
$25.2K
Net Income
Q2 2026
$-2.7M
ROIC
Q2 2026
-68.2%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+65.6% YoYNet Income
-3.4% YoYOperating Income
-27.9% YoYEPS (Diluted)
+99.8% YoYTotal Assets
+543.9% YoYOp. Cash Flow
-35.9% YoYFree Cash Flow
-36.2% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $75.7K +65.6% | $45.7K -39.4% | $75.4K +24.8% | $60.4K +0.3% | $60.3K | — |
| Net Income | $-7.2M -3.4% | $-7.0M -42.4% | $-4.9M +30.5% | $-7.1M -42.8% | $-5.0M | — |
| Operating Income | $-7.1M -27.9% | $-5.5M -13.1% | $-4.9M +12.3% | $-5.6M -88.3% | $-3.0M | — |
| EPS (Diluted) | $-4.54 +99.8% | $-2492.97 +90.6% | $-26594.00 -6486241.5% | $-0.41 +93.8% | $-6.58 | — |
| Total Assets | $13.7M +543.9% | $2.1M -13.7% | $2.5M -15.6% | $2.9M +54.3% | $1.9M | — |
| Operating Cash Flow | $-7.2M -35.9% | $-5.3M -44.5% | $-3.6M +26.3% | $-4.9M -106.2% | $-2.4M | — |
| Free Cash Flow | $-7.2M -36.2% | $-5.3M -44.7% | $-3.6M | — | — | — |
Get alerted when ACON's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Aclarion, Inc. including:
Top Institutional Holders of ACON
BRIDGEWAY CAPITAL MANAGEMENT, LLC
$56.1K19,480 shCAPTRUST FINANCIAL ADVISORS
$49.1K17,059 shVANGUARD FIDUCIARY TRUST CO
$46.2K16,028 shSUSQUEHANNA INTERNATIONAL GROUP, LLP
$44.2K15,355 shGEODE CAPITAL MANAGEMENT, LLC
$34.9K12,128 shXTX Topco Ltd
$31.8K11,038 shBANK OF MONTREAL /CAN/
$28.8K10,000 shVANGUARD CAPITAL MANAGEMENT LLC
$19.5K6,782 shOSAIC HOLDINGS, INC.
$14.4K5,000 shUBS Group AG
$5.7K1,968 sh
| Fund | Value | Shares |
|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $56.1K | 19,480 |
| CAPTRUST FINANCIAL ADVISORS | $49.1K | 17,059 |
| VANGUARD FIDUCIARY TRUST CO | $46.2K | 16,028 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $44.2K | 15,355 |
| GEODE CAPITAL MANAGEMENT, LLC | $34.9K | 12,128 |
| XTX Topco Ltd | $31.8K | 11,038 |
| BANK OF MONTREAL /CAN/ | $28.8K | 10,000 |
| VANGUARD CAPITAL MANAGEMENT LLC | $19.5K | 6,782 |
| OSAIC HOLDINGS, INC. | $14.4K | 5,000 |
| UBS Group AG | $5.7K | 1,968 |
More Healthcare Companies
View all Healthcare →Put ACON on your watchlist
Track score changes the day Aclarion, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is ACON a good stock to buy?
13F Pro's AI-powered analysis of Aclarion, Inc. (ACON) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ACON are available on the ACON stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. ACON is classified as a small company.
Which hedge funds own ACON?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ACON. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Aclarion, Inc.'s investment landscape.